Funding for this research was provided by:
Received: 4 February 2019
Accepted: 9 August 2019
First Online: 19 August 2019
Ethics approval and consent to participate
: Ethical approval was obtained from the Bioethical Committee of the institute (Quaid I Azam University Islamabad). Further the Rehman Medical Institute- Research Ethics Committee and the senior management officer Dr. Muhammad Tahir Aziz, Chief Operating Officer, SKMCH&RC, Peshawar and head of pharmacy Dr. Abdul Wahab from both settings approved the research. Patient consent was taken in Urdu/English language before collecting the data.There were several reasons for verbal consent.1. The patients in Khyber Pakhtunkhwa are mostly illiterate because of which the researcher need to translate verbally the purpose of study or data collection.2. No interventions/changes were directly made to any medication order of the patient by the researches.3. The ethics committee observed no harm to the patients from the data collection procedure and also keeping in mind the patients educational background allowed to take verbal consents.4. The consent was documented on a consent form designed both in English and Urdu languages.
: Not applicable.
: The authors declare that they have no competing interests.